controlled substances prescription monitoring program · controlled substances prescription...
TRANSCRIPT
![Page 1: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/1.jpg)
Controlled Substances Prescription Monitoring Program
Doug Skvarla, RPhCSPMP Director
Arizona State Board of Pharmacy
![Page 2: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/2.jpg)
Conflict of Interest Disclosure
Faculty Disclosure Declaration:I have no actual or potential conflict of interest in relation to this program or presentation.
![Page 3: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/3.jpg)
2018 Special Session Law
![Page 4: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/4.jpg)
The following will affect prescribers and goes into effect April 26, 2018
Prescribers can no longer dispense schedule II opioids out of office. (exception is MAT treatment)
Prescribing limit of initial opioid prescriptions reduced to a 5-day supply. Exception, is that following a surgical procedure a 14 day supply can be prescribed for an opioid naive patient.(exceptions for oncology, hospice, MAT)
Initial prescriptions of opioids cannot exceed 90 MME/day (morphine milligram equivalents)
![Page 5: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/5.jpg)
Effective 2019:• Mandatory electronic prescribing for schedule
II opioids
Large counties (greater than 150,000 people) starts January 1, 2019:Maricopa, Pima, Pinal, Yavapai, Mohave, and Yuma
Small counties (less than 150,000 people) starts July 1, 2019:Greenlee, La Paz, Graham, Santa Cruz, Gila, Apache, Navajo, Cochise, and Coconino
![Page 6: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/6.jpg)
The following will affect pharmacists April 26, 2018
• Schedule 2 opioids must be dispensed with a red cap and warning label about potential addiction.
![Page 7: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/7.jpg)
The following will affect pharmacists April 26, 2018
• Pharmacists will now be required to check the CSPMP and obtain a patient utilization report for the previous 12 months before dispensing a new prescription for a schedule 2 drug.
![Page 8: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/8.jpg)
Effective 2019:• Pharmacies must be able to accept electronic
prescriptions in order to dispense scheduled II opioids. Prescribers will no longer be able to hand write schedule II opioid prescriptions.
Large counties (greater than 150,000 people) starts January 1, 2019
Small counties (less than 150,000 people) starts July 1, 2019
![Page 9: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/9.jpg)
CSPMP Data Collection & Frequency
• The CSPMP is a centralized, electronic database of all dispensers of controlled substances (II-V)
• Dispensers include pharmacies and prescribers that dispense controlled medications out of the office
• Dispensers upload daily, including medical practitioners
![Page 10: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/10.jpg)
Why use the PMP?
Ensure deliverance of optimal healthcare Identify, deter, and prevent diversion Safeguarding your DEA number Tool to facilitate appropriate CS prescribing Compliance with mandate DHS requires prescribers who write for
medical marijuana certificates to look up their patient in the PMP
![Page 11: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/11.jpg)
A.R.S. 36-2606 Mandates PMP Use
The prescriber mandate went into effect October 16, 2017:“… a medical practitioner, before prescribing an opioid analgesic or benzodiazepine controlled substance listed in schedule II, III or IV for a patient, shall obtain a patient utilization report regarding the patient for the preceding twelve months from the controlled substances prescription monitoring program's central database tracking system at the beginning of each new course of treatment and at least quarterly while that prescription remains a part of the treatment. …”
Starting April 26, 2018 dispensing pharmacists must also review patient reports in the PMP.
![Page 12: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/12.jpg)
CSPMP Registration
https://pharmacypmp.az.gov
![Page 13: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/13.jpg)
CSPMP Registrations
0
5000
10000
15000
20000
25000
30000
Law Enforcement Prescribers Pharmacists Prescriber Delegates Pharmacy Delegates
6/1/2017 12/1/2017
![Page 14: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/14.jpg)
Patient Lookups By Month, 2017
![Page 15: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/15.jpg)
Who Has Access To The CSPMP?
Prescribers who have a DEA registration Pharmacists Delegates Medical Examiners Licensing Boards (Starting April 26th, 2018)
The following must provide written request for records:1. Local, state or federal law enforcement (i.e.
DEA)2. AHCCCS (Arizona Health Care Cost
Containment System)
![Page 16: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/16.jpg)
How Do I Register for the PMP?
• Log in to: https://arizona.pmpaware.net
Select Create an Account from the main login screen.
![Page 17: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/17.jpg)
How to create an account
You will be prompted to enter a unique email address and create a password. The email address you enter will be used as your login ID and as the primary email address for your account. Password requires a minimum of 8 characters and must include one uppercase, one lowercase, and one symbol.
Click Save & Continue to create your account credentials and move on
![Page 18: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/18.jpg)
About Role Selection & the Registry Form
Click the Category Name to expand it and see the roles. Select only one, then click Save and Continue.
![Page 19: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/19.jpg)
How Do I Register for the PMP?
After filling in all the information required, click on the “Submit Your Registration” button.
![Page 20: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/20.jpg)
Verify Your Email• Registration is not automatic
1. Look for an email from [email protected], click the link “verify your email” (check your junk mail folder)
2. ASBP staff verifies and approves registration after your email address has been verified.
![Page 21: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/21.jpg)
Delegate Role
• While providers and pharmacist are not able to share their online account for the Controlled Substances Prescription Monitoring Program (PMP), they may still have delegates run their PMP reports. Delegates register for their own account, and the provider controls their access by approving or removing the delegate’s access within the providers PMP account.
• Once a delegate has registered for the PMP, the provider/pharmacist must approve a delegate before the delegate can gain access.
![Page 22: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/22.jpg)
Delegate Role
Delegates can:• Run a patient report for a prescriber/pharmacistDelegates cannot:• Keep track of what a prescriber or pharmacist
prescribes/dispenses• Have access to a prescriber/pharmacist account to
keep the account updatedWhy:• A PMP account is to be accessible by the owner of
the account only. By law, PMP accounts is not to be shared with anyone, including employees and other users of the PMP.
![Page 23: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/23.jpg)
PatientPMP Records
![Page 24: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/24.jpg)
How Do I Access Records?
• Log into: https://Arizona.pmpaware.net
• Click on Menu
• Under RxSearch, click on Patient Request.
![Page 25: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/25.jpg)
• Enter patient information
• Click the I agree to terms box
• Click on the Search Button
![Page 26: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/26.jpg)
Patient Report Top Half
![Page 27: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/27.jpg)
Patient Report Bottom Half
![Page 28: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/28.jpg)
What should I do if…
I find incorrect information in a CSPMP report?
Confirm that the CSPMP data is correct by contacting the dispensing pharmacy
Fraudulent activity is discovered?Contact local law enforcement
![Page 29: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/29.jpg)
What should I do if…
I look at the CSPMP report and have concerns about the patient’s health and safety. What next?
Ask open ended questions to patient about medication use
Consult with other healthcare professionals involved with the patient’s care
Discuss areas of concern with patient, emphasizing interest in patient safety
Make a professional decision
![Page 30: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/30.jpg)
PMP Gateway Integration into EHRs
![Page 31: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/31.jpg)
Integration: PMP Gateway
• Arizona’s law allows the use of electronic medical records that integrate data from the PMP as compliant with the law [A.R.S. 36-2606(H)]
• The Arizona State Board of Pharmacy received funding to pay for the PMP Gateway for healthcare systems in Arizona
• We are currently working to get healthcare systems, from large hospital systems to individual prescribing offices, using the PMP Gateway
• Pharmacies can integrate too
![Page 32: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/32.jpg)
Integration Can Help Your EHR Turn This Workflow...
EHR
Prescriber Exits EHR Workflow
Navigate to State Website & Manually Login
Navigate to Search
View PDMP Report
Manually Enter Patient Identifiers
Wait for Report to Be Generated
Interpret Report Data
Prescriber Returns to EHR Workflow
Repeat Steps to Navigate to Neighboring State(s) PDMP as
necessary
More Data Needed?
4.22 MINUTES PER PATIENT Source: http://onlinelibrary.wiley.com/doi/10.1111/acem.12905/abstract
![Page 33: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/33.jpg)
Into THIS Workflow
Prescriber navigates to their normal prescription workflow in the patient chart
CLICKShow Report
button
Prescriber reviews prescription history report and continues with normal prescription workflow
Source: Appriss Health
![Page 34: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/34.jpg)
Integration: PMP Gateway
• Healthcare entities – large and small – who are interested in connecting to the PMP more efficiently should fill out the online integration interest form:https://pharmacypmp.az.gov/integration-interest-form.
• The PMP Gateway requires prescribers to have registration in the PMP at https://arizona.pmpaware.net/login. To find out whether your prescribers are registered, contact [email protected].
![Page 35: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/35.jpg)
Prescriber Reports
![Page 36: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/36.jpg)
Prescriber ReportsTop Half
![Page 37: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/37.jpg)
Prescriber ReportsBottom Half
![Page 38: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/38.jpg)
• The largest amount of prescriber questions and concerns are regarding three areas.– Delegate searches– MME (morphine milligram equivalents) – Registration specialty
Prescriber Reports
![Page 39: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/39.jpg)
• Concern 1: Delegate Searches– Concern is that more searches were completed by
prescriber than what the report show.
• Delegates for more than one provider, must select the correct provider for which the delegate running the patient report.
• The amount of searches are a monthly average
Prescriber Reports
![Page 40: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/40.jpg)
Concern 2 Daily MME (morphine milligram equivalents) – Concern is that buprenorphine has a high MME conversion
factor (30:1)– Buprenorphine can be used a couple of different ways
• MAT (medication assisted therapy)• Pain management
– CDC is now recommending that buprenorphine to be removed from the MME calculation. This will be reflected in late March or early April, but it will still populate on the patient reports.
Prescriber Reports
![Page 41: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/41.jpg)
Prescriber Reports
• Concern 3: Healthcare Specialty
Concern is that the prescriber is not being compared to a similar prescriber
• In registration you must take the time to select your specialty accurately
![Page 42: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/42.jpg)
Calculating MME
![Page 43: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/43.jpg)
Calculating MME
![Page 44: Controlled Substances Prescription Monitoring Program · Controlled Substances Prescription Monitoring Program Doug Skvarla, RPh CSPMP Director Arizona State Board of Pharmacy](https://reader030.vdocuments.site/reader030/viewer/2022040417/5d52e66188c99390778bddff/html5/thumbnails/44.jpg)
QUESTIONS?
Arizona State Board of PharmacyWeb page: pharmacyPMP.AZ.gov
Doug Skvarla, CSPMP DirectorArizona State Board of Pharmacy
P.O. Box 18520Phoenix, AZ 85005
602-771-2744Fax: 602-771-2748